shortagewatch

Home / Digestive tract and metabolism / Insulin (Human)

ATC A10AD01 · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-Acting

Insulin (Human) shortage

As of 2 Nov 2026, Insulin (Human) has a reported shortage in 1 of the 15 countries we track (Canada), covering 1 product from 1 company.

Countries1/15
Products1packs or presentations
Companies11 listed
Short since–
Earliest return18 Sep 2027company estimate
Main reasonNot stated
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage

Which companies are short

products short, all countries
Eli Lilly1 LLY

Listed: Eli Lilly LLY · NYSE

Compared with similar medicines

ATC group A10AD · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-Acting
Insulin (Human)1/15Insulin Aspart1/15Insulin Lispro1/15

Affected products

CountryProductCompanySinceExpected backReason
CAHUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) (Vial HI0710, 10 mL, 100 units/mL) discontinuationELI LILLY CANADA INCnot given18 Sep 2027Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.